Supplementary Figure 1 from Promoter Methylation Analysis Reveals That <i>KCNA5</i> Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation

KCNA5 promoter methylation in diverse cancer types</p

Supplementary Figures 1-4 from Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice

Supplementary Figures 1-4 from Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mic

Perspective from Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice

Perspective from Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mic

Supplementary Figure 1 from DNA Hypermethylation of <i>ESR1</i> and <i>PGR</i> in Breast Cancer: Pathologic and Epidemiologic Associations

Supplementary Figure 1 from DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Association

Supplementary Table 1 from DNA Hypermethylation of <i>ESR1</i> and <i>PGR</i> in Breast Cancer: Pathologic and Epidemiologic Associations

Supplementary Table 1 from DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Association

Supplementary Figure 5 from Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

ER DNA methylation in hormone-resistant tumor biopsies.</p

Supplementary Figure 1 from Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Kaplan-Meier curves for survival after disease progression among women with advanced hormone-resistant breast cancer by optional continuation (blue curve) or event monitoring (red curve). The 95% confidence limits are shaded; Tick marks indicate censored data.</p

Supplementary Figure 3 from Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Gene list and biological pathways of significant differentially expressed genes in hormone-resistant breast cancer volcano plot.</p

Supplemental Table 1 from Association of the Colorectal CpG Island Methylator Phenotype with Molecular Features, Risk Factors, and Family History

Supplemental Table 1. Distribution of CIMP status1 by selected characteristics</p

Supplementary Table and Figure Legends from Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Supplementary Table and Figure Legends</p